Breast Cancer Information

Lets Start Screening For Breast Health


In the United States, American women are told to begin annual mammographic screening for breast cancer at the age of 40. Long before we've reached this age, we are advised to perform a monthly breast exam and see our doctors for a clinical breast exam (CBE) annually as well. However, the detection rate of breast cancer for CBE is only 47% when the tumors are less than 1 centimeter while mammography has given us a 70% detection rate. By the time a tumor is detected by palpation or found mammographically, it has already been growing and developing for 8-10 years.

Mammography has a high false positive rate. Only 1:6 biopsies are found to be positive for cancer when performed due to a positive mammogram or CBE. This places additional stressors on women who undergo these procedures.

Other risks of mammography include the radiation that each breast is exposed to during a mammogram. During a chest X-ray, a person receives 1/1000 of a RAD, or radiation absorbed dose. This type of X-ray is a high energy X-ray. During a mammogram, however, the X-ray used is a low energy X-ray and results in 1 RAD or a 1000-fold greater exposure than a simple chest X-ray. It has been suggested that the low energy X-ray used may cause greater biological damage which is cumulative over time. In a journal entitled Radiation Research and published in 2004, the author concludes that the risks associated with mammography screening may be FIVE times higher than previously assumed and the risk-benefit relationship of mammography exposures need to be re-examined.

In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. Digital Infrared Thermal Imaging, also known as DITI measures heat emitted from the body and is accurate to 1/100th of a degree. Certified Clinical Thermographers follow strict guidelines and transmit their scans for interpretation by board certified thermologists. DITI examines physiology, NOT structure. It is in this capacity that DITI can monitor breast HEALTH over time and alert a patient or physician to a developing problem; possibly before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. Women with cosmetic implants are great candidates for thermography which emits no radiation and no compression. Contact is never made during a thermographic scan.

Clinical research studies continue to support thermography's role as an adjunctive tool in breast cancer screening and the ONLY tool that measures breast health. There are now more than 800 publications on over 300,000 women in clinical trials. A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not present.

In conclusion, women need to begin breast health screening early; as young as age 25. This can provide women with the earliest possible indication that further investigation is necessary. It takes approximately 15 years for a breast cancer to form and lead to death. If "early detection is the best prevention," let's start using technology that truly allows for the earliest possible alert to a developing problem.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.


MORE RESOURCES:
Google

dBTechno

Low Levels of Vitamin D Spell Trouble for Breast Cancer Patients
U.S. News & World Report, DC - 1 hour ago
By Amanda Gardner FRIDAY, May 16 (HealthDay News) -- Women with breast cancer who have a vitamin D deficiency at the time of diagnosis are more likely to ...
Vitamin D deficiency linked to poorer breast cancer outcomes: study The Canadian Press
Breast cancer linked to Vitamin D deficiency Hindu
More Aggressive Breast Cancer Linked to Vitamin D Deficiency ABC News
Los Angeles Times - Globe and Mail
all 214 news articles


Victim of bungled breast cancer tests urges others to get second ...
The Canadian Press, TORONTO - 1 hour ago
TORONTO ? For most women, there are few more terrifying words to hear than: "You have breast cancer." Unless, of course, it's being told the recommended ...


Blood Test Helps Docs Assess Breast Cancer Treatment
U.S. News & World Report, DC - 1 hour ago
In this study, Liu and colleagues measured the number of circulating tumor cells (CTC) in blood samples collected from metastatic breast cancer patients ...


AFP

Vitamin D deficiency linked to breast cancer in new study
AFP - 4 hours ago
WASHINGTON (AFP) ? Women deficient in vitamin D at the time of a breast cancer diagnosis are more likely to die or see the tumor spread, a Canadian study ...


GlxoSmithKline: Drug combo study shows positive result in treating ...
Forbes, NY - 41 minutes ago
... data from a Phase III trial of the combination of two targeted agents, Tykerb and trastuzumab, in women with HER2-positive metastatic breast cancer. ...


TopNews

Physical activity may prevent breast cancer
Times of India, India - 8 hours ago
A new study has found that women who engage in physical activity are 25 per cent less likely to develop breast cancer. However, researchers also discovered ...
Link Between Vitamin D Status And Breast Cancer Illuminated Science Daily (press release)
Exercise when young may cut breast cancer Los Angeles Times
Regular Aspirin Intake Cuts Breast Cancer Risk Medi News Direct
Jackson Sun - MedIndia
all 510 news articles


Vitamin D may help curb breast cancer, study finds
The Associated Press - 10 hours ago
Breast cancer patients with low levels of vitamin D were much more likely to die of the disease or have it spread than patients getting enough of the ...


Eisai says drug active in advanced breast cancer
Reuters - 9 hours ago
T: Quote, Profile, Research) said on Friday that its experimental treatment for advanced breast cancer had shown tumour fighting activity in mid-stage ...


Brocktown News

Herceptin enhances Tykerb for breast cancer -study
guardian.co.uk, UK - 13 hours ago
Both drugs are designed to treat, in different ways, the 25 percent to 30 percent of breast cancer patients who have tumors that generate a protein called ...
Drug combo helps women with advanced breast cancer The Associated Press
Drug combo helps women with advanced breast cancer XETV FOX6 San Diego
Drug combo helps women with advanced breast cancer WBXH
all 156 news articles


Failed lung cancer drug has breast cancer promise
guardian.co.uk, UK - 14 hours ago
Combining Iressa with the breast cancer drug Arimidex helped women survive 45 percent longer without the cancer coming back than using Arimidex alone, ...

Breast-Cancer - Google News

home | site map
© 2006